"Enrichment FDR","nGenes","Pathway Genes","Fold Enrichment","Pathway","URL","Genes"
0.00390946135754264,4,109,17.1361168320539,"Path:hsa04066 HIF-1 signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04066 "," PLCG2  PRKCB  ELOC  ELOB"
0.00390946135754264,5,210,11.1180758017493,"Path:hsa05170 Human immunodeficiency virus 1 infection","http://www.genome.jp/kegg-bin/show_pathway?hsa05170 "," SAMHD1  PLCG2  PRKCB  ELOC  ELOB"
0.00390946135754264,5,202,11.5583956354819,"Path:hsa05205 Proteoglycans in cancer","http://www.genome.jp/kegg-bin/show_pathway?hsa05205 "," ANK2  PLCG2  PRKCB  VAV1  ARHGEF1"
0.019920897522037,4,191,9.77924991986323,"Path:hsa04062 Chemokine signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04062 "," DOCK2  PLCG2  PRKCB  VAV1"
0.019920897522037,3,81,17.2947845804989,"Path:hsa04662 B cell receptor signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04662 "," PLCG2  PRKCB  VAV1"
0.0263827599750748,3,97,14.4420366084578,"Path:hsa04666 Fc gamma R-mediated phagocytosis","http://www.genome.jp/kegg-bin/show_pathway?hsa04666 "," PLCG2  PRKCB  VAV1"
0.0359537181773232,3,114,12.2883995703545,"Path:hsa04670 Leukocyte transendothelial migration","http://www.genome.jp/kegg-bin/show_pathway?hsa04670 "," PLCG2  PRKCB  VAV1"
0.0456974929173888,3,130,10.7759811616954,"Path:hsa04650 Natural killer cell mediated cytotoxicity","http://www.genome.jp/kegg-bin/show_pathway?hsa04650 "," PLCG2  PRKCB  VAV1"
0.0692559482156861,2,50,18.6783673469388,"Path:hsa00330 Arginine and proline metabolism","http://www.genome.jp/kegg-bin/show_pathway?hsa00330 "," ALDH2  SMS"
0.0692559482156861,3,169,8.28921627822727,"Path:hsa04530 Tight junction","http://www.genome.jp/kegg-bin/show_pathway?hsa04530 "," DLG2  DLG3  CGN"
0.0692559482156861,5,530,4.40527531767424,"Path:hsa05200 Pathways in cancer","http://www.genome.jp/kegg-bin/show_pathway?hsa05200 "," PLCG2  PRKCB  ELOC  ELOB  ARHGEF1"
0.0733036002258681,2,57,16.3845327604726,"Path:hsa00480 Glutathione metabolism","http://www.genome.jp/kegg-bin/show_pathway?hsa00480 "," RRM2B  SMS"
0.0733036002258681,2,59,15.8291248702871,"Path:hsa04370 VEGF signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04370 "," PLCG2  PRKCB"
0.0835546246310314,2,68,13.734093637455,"Path:hsa04664 Fc epsilon RI signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04664 "," PLCG2  VAV1"
0.0835546246310314,2,68,13.734093637455,"Path:hsa05211 Renal cell carcinoma","http://www.genome.jp/kegg-bin/show_pathway?hsa05211 "," ELOC  ELOB"
0.0840180916173403,2,75,12.4522448979592,"Path:hsa05214 Glioma","http://www.genome.jp/kegg-bin/show_pathway?hsa05214 "," PLCG2  PRKCB"
0.0840180916173403,2,72,12.9710884353741,"Path:hsa05223 Non-small cell lung cancer","http://www.genome.jp/kegg-bin/show_pathway?hsa05223 "," PLCG2  PRKCB"
0.0840180916173403,3,214,6.5461567804692,"Path:hsa05417 Lipid and atherosclerosis","http://www.genome.jp/kegg-bin/show_pathway?hsa05417 "," MIB1  VAV1  ARHGEF1"
0.0878951207866657,2,79,11.8217514854043,"Path:hsa01521 EGFR tyrosine kinase inhibitor resistance","http://www.genome.jp/kegg-bin/show_pathway?hsa01521 "," PLCG2  PRKCB"
0.089370073139503,2,84,11.1180758017493,"Path:hsa04012 ErbB signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04012 "," PLCG2  PRKCB"
0.089370073139503,3,235,5.96118106817195,"Path:hsa04014 Ras signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04014 "," PLCG2  PRKCB  RASA2"
0.107549616048083,2,108,8.64739229024943,"Path:hsa03013 Nucleocytoplasmic transport","http://www.genome.jp/kegg-bin/show_pathway?hsa03013 "," IPO8  PHAX"
0.107549616048083,2,104,8.97998430141287,"Path:hsa04064 NF-kappa B signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04064 "," PLCG2  PRKCB"
0.107549616048083,2,97,9.62802440563854,"Path:hsa04070 Phosphatidylinositol signaling system","http://www.genome.jp/kegg-bin/show_pathway?hsa04070 "," PLCG2  PRKCB"
0.107549616048083,2,104,8.97998430141287,"Path:hsa04625 C-type lectin receptor signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04625 "," PLCG2  BCL3"
0.107549616048083,2,98,9.52977925864223,"Path:hsa04750 Inflammatory mediator regulation of TRP channels","http://www.genome.jp/kegg-bin/show_pathway?hsa04750 "," PLCG2  PRKCB"
0.107549616048083,2,106,8.81055063534848,"Path:hsa04928 Parathyroid hormone synthesis secretion and action","http://www.genome.jp/kegg-bin/show_pathway?hsa04928 "," PRKCB  ARHGEF1"
0.107549616048083,2,100,9.33918367346939,"Path:hsa04933 AGE-RAGE signaling pathway in diabetic complications","http://www.genome.jp/kegg-bin/show_pathway?hsa04933 "," PLCG2  PRKCB"
0.123934153585753,2,121,7.71833361443751,"Path:hsa04919 Thyroid hormone signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04919 "," PLCG2  PRKCB"
0.123934153585753,2,120,7.78265306122449,"Path:hsa04935 Growth hormone synthesis secretion and action","http://www.genome.jp/kegg-bin/show_pathway?hsa04935 "," PLCG2  PRKCB"
0.12547460361404,2,124,7.53159973666886,"Path:hsa04611 Platelet activation","http://www.genome.jp/kegg-bin/show_pathway?hsa04611 "," PLCG2  ARHGEF1"
0.140137118761271,2,134,6.9695400548279,"Path:hsa04270 Vascular smooth muscle contraction","http://www.genome.jp/kegg-bin/show_pathway?hsa04270 "," PRKCB  ARHGEF1"
0.141494895568735,2,137,6.81692238939371,"Path:hsa05135 Yersinia infection","http://www.genome.jp/kegg-bin/show_pathway?hsa05135 "," VAV1  ARHGEF1"
0.14659069353253,2,142,6.57688991089393,"Path:hsa04120 Ubiquitin mediated proteolysis","http://www.genome.jp/kegg-bin/show_pathway?hsa04120 "," ELOC  ELOB"
0.160285148349492,1,22,21.2254174397032,"Path:hsa00340 Histidine metabolism","http://www.genome.jp/kegg-bin/show_pathway?hsa00340 "," ALDH2"
0.160285148349492,1,20,23.3479591836735,"Path:hsa00670 One carbon pool by folate","http://www.genome.jp/kegg-bin/show_pathway?hsa00670 "," ALDH1L1"
0.160285148349492,1,21,22.2361516034985,"Path:hsa00770 Pantothenate and CoA biosynthesis","http://www.genome.jp/kegg-bin/show_pathway?hsa00770 "," ALDH2"
0.160285148349492,2,157,5.94852463278305,"Path:hsa04390 Hippo signaling pathway","http://www.genome.jp/kegg-bin/show_pathway?hsa04390 "," DLG2  DLG3"
0.160285148349492,2,161,5.80073520091266,"Path:hsa05206 MicroRNAs in cancer","http://www.genome.jp/kegg-bin/show_pathway?hsa05206 "," PLCG2  PRKCB"
0.166835630161239,2,167,5.59232555297568,"Path:hsa05225 Hepatocellular carcinoma","http://www.genome.jp/kegg-bin/show_pathway?hsa05225 "," PLCG2  PRKCB"
0.194231727922094,1,30,15.565306122449,"Path:hsa00053 Ascorbate and aldarate metabolism","http://www.genome.jp/kegg-bin/show_pathway?hsa00053 "," ALDH2"
0.194231727922094,1,30,15.565306122449,"Path:hsa00630 Glyoxylate and dicarboxylate metabolism","http://www.genome.jp/kegg-bin/show_pathway?hsa00630 "," PGP"
0.194231727922094,2,189,4.94136702299968,"Path:hsa04613 Neutrophil extracellular trap formation","http://www.genome.jp/kegg-bin/show_pathway?hsa04613 "," PLCG2  PRKCB"
0.195940788331747,1,31,15.0631994733377,"Path:hsa00410 beta-Alanine metabolism","http://www.genome.jp/kegg-bin/show_pathway?hsa00410 "," ALDH2"
0.198446545962453,2,197,4.74070237231949,"Path:hsa05130 Pathogenic Escherichia coli infection","http://www.genome.jp/kegg-bin/show_pathway?hsa05130 "," MYO1G  ARHGEF1"
0.199307859227245,2,200,4.66959183673469,"Path:hsa04510 Focal adhesion","http://www.genome.jp/kegg-bin/show_pathway?hsa04510 "," PRKCB  VAV1"
